(Q61907114)
Statements
Randomized Double-Blind, Placebo-Controlled Parallel Multi-Center Study to Assess the Efficacy of Cannabidiol (BRCX014) Combined With Standard-Of-Care Treatment in Subjects With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies (English)
0 references
15 January 2019
0 references
30 June 2020
0 references
160
0 references
18 year
0 references
80 year
0 references